Agios Pharmaceuticals | AGIO - 净收入



金融业
股票价格
USD
资产
USD 1.18B
现金及等价物
USD 113.6M
销售成本
USD 1.32M
流动资产
USD 834.84M
流动负债
USD 58.85M
债务
USD 40.21M
EBIT
USD -110.03M
EBITDA
USD -120.31M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.11B
销售毛利
USD 18.09M
债务利息支出
USD 1.18B
利息收入
USD 12.41M
贷款资金
USD 1.06M
市值
USD 1.53B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -109.06M
销售收入
USD 18.8M
销售和管理费用
USD 38.46M
股票
USD 35.09M
贸易债权人
USD 13.75M
应收帐款人
USD 16.13M


净收入 更改 日
AbbVie USD 695M 1.12B 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Astellas Pharma JPY 43.52B 56.86B 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12